跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MCT4 inhibitors (cancer)
首页
药物
MCT4 inhibitors (cancer)
MCT4 inhibitors (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Monocarboxylate transporter 4 (MCT4) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer
申请人: UNIV BRITISH COLUMBIA
优先权: 2015
CN
US
3 件公开
MCT4 inhibitors and uses thereof
申请人: CHARLES R DREW UNIV OF MEDICINE AND SCIENCE
优先权: 2019
US
MONOCARBOXYLATE TRANSPORTERS EXPRESSED IN CANCER CELLS
申请人: XENOPORT INC
优先权: 2004
US
2 件公开
Chromenone inhibitors of monocarboxylate transporters
申请人: SCRIPPS RESEARCH INST
优先权: 2016
US
Pteridine dione monocarboxylate transporter inhibitors
申请人: SCRIPPS RESEARCH INST
优先权: 2016
US
2 件公开
药物
反馈